Cargando…

Epigenetic dysregulation in meningiomas

BACKGROUND: Meningiomas are the most common primary brain tumor. Though typically benign with a low mutational burden, tumors with benign histology may behave aggressively and there are no proven chemotherapies. Although DNA methylation patterns distinguish subgroups of meningiomas and have higher p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wedemeyer, Michelle A, Muskens, Ivo, Strickland, Ben A, Aurelio, Oscar, Martirosian, Vahan, Wiemels, Joseph L, Weisenberger, Daniel J, Wang, Kai, Mukerjee, Debraj, Rhie, Suhn K, Zada, Gabriel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Basic and Translational Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9234763/ https://www.ncbi.nlm.nih.gov/pubmed/35769412 http://dx.doi.org/10.1093/noajnl/vdac084

Ejemplares similares

Pediatric glioma and medulloblastoma risk and population demographics: a Poisson regression analysis
por: Muskens, Ivo S, et al.
Publicado: (2020)

Immune factors preceding diagnosis of glioma: a Prostate Lung Colorectal Ovarian Cancer Screening Trial nested case–control study
por: Muskens, Ivo S, et al.
Publicado: (2019)

Pleiotropic MLLT10 variation confers risk of meningioma and estrogen-mediated cancers
por: Walsh, Kyle M, et al.
Publicado: (2022)

Genome-wide association analysis identifies a meningioma risk locus at 11p15.5
por: Claus, Elizabeth B, et al.
Publicado: (2018)

Tumor-associated macrophage infiltration in meningioma
por: Proctor, Dustin T, et al.
Publicado: (2019)

Identification of shared genomic aberrations between angiomatous and microcystic meningiomas
por: Kuroi, Yasuhiro, et al.
Publicado: (2019)

The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma
por: Horbinski, Craig, et al.
Publicado: (2021)

Gemcitabine radiosensitization primes irradiated malignant meningioma cells for senolytic elimination by navitoclax
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Roles for hENT1 and dCK in gemcitabine sensitivity and malignancy of meningioma
por: Yamamoto, Masahiro, et al.
Publicado: (2021)

Constitutive activation of the EGFR–STAT1 axis increases proliferation of meningioma tumor cells
por: Ferluga, Sara, et al.
Publicado: (2020)

Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment
por: Portet, Sylvain, et al.
Publicado: (2019)

H3K27me3 loss indicates an increased risk of recurrence in the Tübingen meningioma cohort
por: Behling, Felix, et al.
Publicado: (2020)

The CREB-binding protein inhibitor ICG-001: a promising therapeutic strategy in sporadic meningioma with NF2 mutations
por: Deng, Jiaojiao, et al.
Publicado: (2020)

Mitochondrial 1555 G>A variant as a potential risk factor for childhood glioblastoma
por: Li, Shaobo, et al.
Publicado: (2022)

Identification of subsets of IDH-mutant glioblastomas with distinct epigenetic and copy number alterations and stratified clinical risks
por: Li, Kay Ka-Wai, et al.
Publicado: (2019)

Glycolytic expression in lower-grade glioma reveals an epigenetic association between IDH mutation status and PDL1/2 expression
por: Givechian, Kevin B, et al.
Publicado: (2020)

Birth characteristics and risk of meningioma in a population-based study in California
por: Cote, David J, et al.
Publicado: (2022)

Corrigendum to: Epigenetic dysregulation in meningiomas
Publicado: (2023)

TP53, ATRX alterations, and low tumor mutation load feature IDH-wildtype giant cell glioblastoma despite exceptional ultra-mutated tumors
por: Cantero, Diana, et al.
Publicado: (2020)

Dysregulated bioenergetics: a key regulator of joint inflammation
por: Biniecka, M, et al.
Publicado: (2016)

Structural gray matter alterations in glioblastoma and high-grade glioma—A potential biomarker of survival
por: Lamichhane, Bidhan, et al.
Publicado: (2023)

Germline rearrangements in families with strong family history of glioma and malignant melanoma, colon, and breast cancer
por: Andersson, Ulrika, et al.
Publicado: (2014)

Dysregulated CD4(+) T cells from SLE-susceptible mice are sufficient to accelerate atherosclerosis in LDLr(−/−) mice
por: Wilhelm, Ashley J, et al.
Publicado: (2015)

Osteopontin regulates human glioma cell invasiveness and tumor growth in mice
por: Jan, Hsun-Jin, et al.
Publicado: (2010)

Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice
por: de Groot, John F., et al.
Publicado: (2010)

Chloroquine activates the p53 pathway and induces apoptosis in human glioma cells
por: Kim, Ella L., et al.
Publicado: (2010)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

Activation of the Hedgehog pathway in pilocytic astrocytomas
por: Rush, Sarah Z., et al.
Publicado: (2010)

RNA interference targeting survivin exerts antitumoral effects in vitro and in established glioma xenografts in vivo
por: Hendruschk, Sandy, et al.
Publicado: (2011)

Brain tumor eradication and prolonged survival from intratumoral conversion of 5-fluorocytosine to 5-fluorouracil using a nonlytic retroviral replicating vector
por: Ostertag, Derek, et al.
Publicado: (2012)

Identification of a SOX2-dependent subset of tumor- and sphere-forming glioblastoma cells with a distinct tyrosine kinase inhibitor sensitivity profile
por: Hägerstrand, Daniel, et al.
Publicado: (2011)

Pediatric brain tumor cancer stem cells: cell cycle dynamics, DNA repair, and etoposide extrusion
por: Hussein, Deema, et al.
Publicado: (2011)

Chromosome 17 alterations identify good-risk and poor-risk tumors independently of clinical factors in medulloblastoma
por: McCabe, Martin G., et al.
Publicado: (2011)

CRN2 enhances the invasiveness of glioblastoma cells
por: Ziemann, Anja, et al.
Publicado: (2013)

Functional role of endothelial adhesion molecules in the early stages of brain metastasis
por: Soto, Manuel Sarmiento, et al.
Publicado: (2014)

Silencing of protein kinase D2 induces glioma cell senescence via p53-dependent and -independent pathways
por: Bernhart, Eva, et al.
Publicado: (2014)

Organotypic slice cultures of human glioblastoma reveal different susceptibilities to treatments
por: Merz, Felicitas, et al.
Publicado: (2013)

The soluble form of the tumor suppressor Lrig1 potently inhibits in vivo glioma growth irrespective of EGF receptor status
por: Johansson, Mikael, et al.
Publicado: (2013)

Blockade of SDF-1 after irradiation inhibits tumor recurrences of autochthonous brain tumors in rats
por: Liu, Shie-Chau, et al.
Publicado: (2014)

NCoR controls glioblastoma tumor cell characteristics
por: Heldring, Nina, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_1m6o8g8i2qqu327k3pf73msq5f